TULA TYMB001Recalls & reported problems
Smith & Nephew, Inc. · TYMBION AND SYRINGE PACK · Class 3
All models of TULA (9)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00840128600139), received between Jan 19, 2022 and Jan 15, 2024 — classified as 4 injuries.
The most frequently reported specific device problem is “Therapeutic or Diagnostic Output Failure” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
- Therapeutic or Diagnostic Output Failure1
Patient problems
- Discomfort3
- Inadequate Pain Relief2
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryJan 15, 2024Therapeutic or Diagnostic Output Failure; Therapeutic or Diagnostic Output Failure
IT WAS REPORTED THAT DURING AN IN-OFFICE TULA PROCEDURE, SURGEON FACED DIFFICULTY TO FIND A SIZE FOR AN ATYPICALLY SMALL EAR; SURGEON ATTEMPTED TO USE SIZES 4, 3, 2 AND 1 OF EARPLUGS IN ORDER TO FIND A PROPER SEAL DURING THE FILL. IONTOPHORESIS WAS COMPLETED SUCCESSFULLY WITHOUT ALARMS NOR INTERRUPTIONS; HOWEVER WHEN THE SURGEON TESTED THE TYMPANIC MEMBRANE TO DETERMINE IF IT WAS PROPERLY ANESTHETIZED UTILIZING THE TDS DEVICE, THE PATIENT COMPLAINED OF DISCOMFORT. THE PROCEDURE WAS ULTIMATELY ABORTED AND THE PATIENT RESCHEDULED FOR THE OPERATING ROOM.
Patient problems: Discomfort; Inadequate Pain Relief
MAUDE report 18512422 ↗InjuryApr 6, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING BILATERAL TULA TUBE PLACEMENT, THE TYMBION WAS WARMED UTILIZING THE TYMBION WARMER TO DESIRED TEMPERATURE PRIOR THE PATIENT'S ARRIVAL. THE DOCTOR INSPECTED THE PATIENT'S AUDITORY CANALS AND SIZED THE PATIENT TO A EP3G EARPLUG BILATERALLY BEFORE ASSEMBLING THE BILATERAL KIT. THE PATIENT'S EAR CANALS WERE FILLED WITH TYMBION. IN THE FIRST STAGE OF IONTOPHORESIS THE PATIENT EXPERIENCED SIGNIFICANT DISCOMFORT AND THE DOCTOR SET THE CONTROL UNIT TO REDUCE MODE. THE PATIENT BECAME NON-COMPLIANT AND THE DOCTOR PAUSED THE THERAPY. AFTER A SHORT BREAK TYMBION IONTOPHORESIS WAS RESUMED ON THE PATIENT'S LEFT SIDE, WITH THE LEFT AUDITORY CANAL POSITIONED IN A VERTICAL ORIENTATION. SEVERAL LEAKS AND CONTROL UNIT ALERT LIGHTS WERE OBSERVED BEFORE IONTOPHORESIS WAS CONCLUDED SUCCESSFULLY ON THE PATIENT'S LEFT SIDE. THE DOCTOR THEN REPOSITIONED THE PATIENT AND RESUMED IONTOPHORESIS ON THE PATIENT'S RIGHT SIDE WITH THE RIGHT AUDITORY CANAL POSITIONED IN A VERTICAL ORIENTATION. IONTOPHORESIS WAS CONCLUDED SUCCESSFULLY ON THE PATIENT'S RIGHT SIDE. THE DOCTOR OBSERVED THE ANTERIOR-INFERIOR QUADRANT OF THE TYMPANIC MEMBRANE OF THE PATIENT'S RIGHT EAR UNDER MAGNIFICATION, AND
Patient problems: Discomfort
MAUDE report 14029168 ↗InjuryApr 6, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING A BILATERAL TULA TUBE PLACEMENT, TYMBION WAS WARMED UTILIZING THE TYMBION WARMER TO DESIRED TEMPERATURE PRIOR THE PATIENT'S ARRIVAL. DOCTOR INSPECTED THE PATIENT'S AUDITORY CANALS AND SIZED THE PATIENT TO A EP2B BILATERALLY BEFORE ASSEMBLING THE BILATERAL KIT. THE PATIENT'S AUDITORY CANALS WERE FILLED WITH TYMBION AND NO LEAKS WERE OBSERVED. TYMBION IONTOPHORESIS WAS INITIATED BILATERALLY AND THE PATIENT WAS COOPERATIVE AND AFFABLE THROUGHOUT THE THERAPY. NO DISCOMFORT WAS OBSERVED DURING TYMBION IONTOPHORESIS, WITH THE EXCEPTION OF THE PATIENT ATTEMPTING TO SCRATCH HIS BACK IN THE GENERAL AREA OF THE RETURN ELECTRODE. TYMBION IONTOPHORESIS CONCLUDED SUCCESSFULLY WITHOUT ANY ALERT LIGHTS. WITHIN 15 MINUTES OF THE CONCLUSION OF TYMBION IONTOPHORESIS, DOCTOR REMOVED THE EARSETS, AND AN UNIDENTIFIED BROWN-COLORED LIQUID WAS OBSERVED IN BOTH EARSETS RESERVOIRS. DOCTOR OBSERVED THE ANTERIOR-INFERIOR QUADRANT OF THE TYMPANIC MEMBRANE OF THE PATIENT'S LEFT EAR UNDER MAGNIFICATION, AND THEN ATTEMPTED TO TEST THE TYMPANIC MEMBRANE FOR ADEQUATE ANESTHESIA EMPLOYING A TM-TAP TECHNIQUE WITH THE RETRACTED TIP OF THE TUBE DELIVERY SYSTEM. THE PATIENT IMMEDIATELY DISPL
Patient problems: Discomfort
MAUDE report 14029164 ↗InjuryJan 19, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT, DURING TULA BMT PROCEDURE, THE IONTOPHORESIS PORTION OF THE PROCEDURE WAS SUCCESSFULLY COMPLETED IN NOMINAL MODE, HOWEVER, UPON TESTING THE RIGHT TYMPANIC MEMBRANE (TM) OF THE CHILD (RIGHT EAR DRUM) FOR ADEQUATE ANESTHETIZATION WITH TDS TIP (LEFT SIDE WAS NOT TESTED), IT WAS DETERMINED THAT THE TM WAS NOT ADEQUATELY ANESTHETIZED TO ATTEMPT THE TUBE DEPLOYMENT PORTION OF THE PROCEDURE AND ABORTED THE PROCEDURE. THE PROCEDURE WAS RESCHEDULED FOR OPERATING ROOM.
Patient problems: Inadequate Pain Relief
MAUDE report 13290272 ↗
Other Tympanostomy tube delivery product with drug devices
- TULA 72290090Smith & Nephew, Inc. · Tympanostomy tube delivery product with drug7 reports
- TULA TDS114GSmith & Nephew, Inc. · Tympanostomy tube delivery product with drug5 reports
- TULA TULAKIT2Smith & Nephew, Inc. · Tympanostomy tube delivery product with drug4 reports
- TULA 72290097Smith & Nephew, Inc. · Tympanostomy tube delivery product with drug3 reports
- TULA IOCNTRLSmith & Nephew, Inc. · Tympanostomy tube delivery product with drug2 reports
- TULA 72290098Smith & Nephew, Inc. · Tympanostomy tube delivery product with drug2 reports
- TULA EP1PSmith & Nephew, Inc. · Tympanostomy tube delivery product with drug1 report
- TULA EP2BSmith & Nephew, Inc. · Tympanostomy tube delivery product with drug1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page